{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T04:07:03Z","timestamp":1792901223308,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.psychres.2025.116532","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:12:59Z","timestamp":1746724379000},"page":"116532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review"],"prefix":"10.1016","volume":"349","author":[{"given":"Margery J.Q.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chen-Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Chisamore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Ishrat","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Di Vincenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo B.","family":"Mansur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2000-7691","authenticated-orcid":false,"given":"Danica","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-2523","authenticated-orcid":false,"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4773-2191","authenticated-orcid":false,"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2025.116532_bib0001","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.npp.1395318","article-title":"Serotonin and hallucinogens","volume":"21","author":"Aghajanian","year":"1999","journal-title":"Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.psychres.2025.116532_bib0002","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1073\/pnas.0500055102","article-title":"Identification of combinatorial drug regimens for treatment of Huntington\u2019s disease using Drosophila","volume":"102","author":"Agrawal","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.psychres.2025.116532_bib0003","first-page":"203","article-title":"Use and abuse of dissociative and psychedelic drugs in adolescence","author":"Bates","year":"2021","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.psychres.2025.116532_bib0004","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ijnp\/pyac075","article-title":"Ketanserin reverses the acute response to LSD in a randomized, double-blind, placebo-controlled, crossover study in healthy participants","volume":"26","author":"Becker","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2025.116532_bib0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116532_bib0006","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41398-021-01533-1","article-title":"Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report","volume":"11","author":"Braund","year":"2021","journal-title":"Transl. Psychiatry."},{"key":"10.1016\/j.psychres.2025.116532_bib0007","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-020-3008-z","article-title":"A non-hallucinogenic psychedelic analogue with therapeutic potential","volume":"589","author":"Cameron","year":"2021","journal-title":"Nature"},{"issue":"59","key":"10.1016\/j.psychres.2025.116532_bib0008","first-page":"3638","article-title":"The mouse forced swim test","author":"Can","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"12","key":"10.1016\/j.psychres.2025.116532_bib0009","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/0269881116662634","article-title":"Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences","volume":"30","author":"Carbonaro","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.psychres.2025.116532_bib0010","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/acschemneuro.7b00042","article-title":"The Roden forced swim test measures stress-coping strategy, not depression-like behavior","volume":"8","author":"Commons","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.psychres.2025.116532_bib0011","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acschemneuro.2c00597","article-title":"Pharmacological mechanism of the non-hallucinogenic 5-HT2A agonist Ariadne and analogs","volume":"14","author":"Cunningham","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.psychres.2025.116532_bib0012","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/da.22502","article-title":"Individualized yoga for reducing depression and Anxiety, and improving well-being: a randomized controlled trial","volume":"33","author":"de Manincor","year":"2016","journal-title":"Depress Anxiety"},{"issue":"10","key":"10.1016\/j.psychres.2025.116532_bib0013","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/j.cell.2021.03.043","article-title":"Psychedelic-inspired drug discovery using an engineered biosensor","volume":"184","author":"Dong","year":"2021","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.psychres.2025.116532_bib0014","doi-asserted-by":"crossref","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116532_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107933","article-title":"Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species","volume":"167","author":"Halberstadt","year":"2020","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.psychres.2025.116532_bib0016","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00213-013-3006-z","article-title":"Characterization of the head-twitch response induced by hallucinogens in mice","volume":"227","author":"Halberstadt","year":"2013","journal-title":"Psychopharmacol"},{"issue":"17","key":"10.1016\/j.psychres.2025.116532_bib0017","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.psychres.2025.116532_bib0018","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/1529-1006.00008","article-title":"Treatment and prevention of depression","volume":"3","author":"Hollon","year":"2002","journal-title":"Psychol. Sci. Public. Interest"},{"issue":"4","key":"10.1016\/j.psychres.2025.116532_bib0019","doi-asserted-by":"crossref","first-page":"E134","DOI":"10.1192\/bjo.2023.535","article-title":"Psilocybin for treatment-resistant depression without psychedelic effects : study protocol for a 4-weel, double-blind, proof-of-concept randomised controlled trial","volume":"9","author":"Husain","year":"2023","journal-title":"BJPsych Open"},{"key":"10.1016\/j.psychres.2025.116532_bib0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41398-024-03055-y","article-title":"Epigenetic mechanisms of rapid-acting antidepressants","volume":"14","author":"Inserra","year":"2024","journal-title":"Transl Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2025.116532_bib0021","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/jnc.15536","article-title":"Molecular targets of psychedelic-induced plasticity","volume":"162","author":"Jaster","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.psychres.2025.116532_bib0022","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00540-015-2096-7","article-title":"Effect of intraoperative application of ketamine on postoperative depressed mood in patients undergoing elective orthopedic surgery","volume":"30","author":"Jiang","year":"2016","journal-title":"J. Anesth."},{"key":"10.1016\/j.psychres.2025.116532_bib0023","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jad.2022.09.168","article-title":"Psychedelic therapy for depressive symptoms: a systematic review and meta-analysis","volume":"322","author":"Ko","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.psychres.2025.116532_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112203","article-title":"A non-hallucinogenic LSD analog with therapeutic potential for mood disorders","volume":"42","author":"Lewis","year":"2023","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.psychres.2025.116532_bib0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40263-021-00877-y","article-title":"Molecular mechanisms of psilocybin and implications for the treatment of depression","volume":"36","author":"Ling","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2025.116532_bib0026","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1038\/s41380-021-01159-1","article-title":"An analog of psychedelics restores functional neural circuits disrupted by unpredictable stress","volume":"26","author":"Lu","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2025.116532_bib0027","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.psychres.2025.116532_bib0028","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ynstr.2018.08.002","article-title":"Distinctive stress sensitivity and anxiety-like behavior in female mice: strain differences matter","volume":"9","author":"Marchette","year":"2018","journal-title":"Neurobiol. Stress."},{"key":"10.1016\/j.psychres.2025.116532_bib0029","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbi.2023.09.004","article-title":"Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: an experimental, placebo-controlled study","volume":"114","author":"Mason","year":"2023","journal-title":"Brain Behav. Immun."},{"issue":"10","key":"10.1016\/j.psychres.2025.116532_bib0030","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14740338.2023.2253144","article-title":"Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents","volume":"22","author":"McIntyre","year":"2023","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.psychres.2025.116532_bib0031","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci."},{"issue":"10","key":"10.1016\/j.psychres.2025.116532_bib0032","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nn.2647","article-title":"Animal models of neuropsychiatric disorders","volume":"13","author":"Nestler","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.psychres.2025.116532_bib0033","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/cpt.557","article-title":"Psychedelics as medicines: an emerging new paradigm","volume":"101","author":"Nichols","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.psychres.2025.116532_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109232","article-title":"Psychedelics as potent anti-inflammatory therapeutics","volume":"219","author":"Nichols","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psychres.2025.116532_bib0035","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/acsptsci.0c00192","article-title":"The subjective effects of psychedelics may not Be necessary for their enduring therapeutic effects","volume":"4","author":"Olson","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.psychres.2025.116532_bib0036","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2025.116532_bib0037","first-page":"1700","article-title":"The emerging science of microdosing: a systematic review of research on low dose psychedelics (1955-3032) and recommendations for the field","volume":"398","author":"Polito","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psychres.2025.116532_bib0038","first-page":"7","article-title":"Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor","author":"Preller","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.psychres.2025.116532_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173500","article-title":"Rapid antidepressant-like effect of non-hallucinogenic psychedelic analog lisuride, but not hallucinogenic psychedelic DOI, in lipopolysaccharide-treated mice","volume":"222","author":"Qu","year":"2023","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.psychres.2025.116532_bib0040","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","article-title":"Psychedelics and Psychedelic-assisted psychotherapy","volume":"177","author":"Reiff","year":"2020","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2025.116532_bib0041","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5455\/msm.2020.32.131-134","article-title":"Assessment of the antidepressant side effects occurrence in patients treated in primary care","volume":"32","author":"Ramic","year":"2020","journal-title":"Mater Sociomed"},{"issue":"5","key":"10.1016\/j.psychres.2025.116532_bib0042","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1176\/appi.ajp.20220835","article-title":"Antidepressant effects of psilocybin in the absence of psychedelic effects","volume":"180","author":"Rosenblat","year":"2023","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2025.116532_bib0043","doi-asserted-by":"crossref","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116532_bib0044","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","article-title":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic","volume":"398","author":"Santomauro","year":"2021","journal-title":"Lancet"},{"issue":"96","key":"10.1016\/j.psychres.2025.116532_bib0045","doi-asserted-by":"crossref","DOI":"10.3791\/52434-v","article-title":"Use of the open field maze to measure locomotor and anxiety-like behavior in mice","author":"Seibenhener","year":"2015","journal-title":"J. Vis. Exp."},{"issue":"16","key":"10.1016\/j.psychres.2025.116532_bib0046","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"J. Neuron."},{"issue":"5","key":"10.1016\/j.psychres.2025.116532_bib0047","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1177\/0269881106060764","article-title":"The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy","volume":"20","author":"Sumnall","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116532_bib0048","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"NeuroReport"},{"issue":"11","key":"10.1016\/j.psychres.2025.116532_bib0050","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.drudis.2021.07.023","article-title":"The optimization of combinatorial drug therapies: strategies and laboratorial platforms","volume":"26","author":"Wang","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.psychres.2025.116532_bib0051","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","article-title":"The subjective effects of psychedelics are necessary for their enduring therapeutic effects","volume":"4","author":"Yaden","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125001805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125001805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T09:00:53Z","timestamp":1752570053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178125001805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":50,"alternative-id":["S0165178125001805"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116532","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116532","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116532"}}